6640--NOTICE OF INTENT TO SOLE SOURCE - ILLUMINA REAGENTS
ID: 36C26325Q0263Type: Presolicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNETWORK CONTRACT OFFICE 23 (36C263)Saint Paul, MN, 55101, USA

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

PSC

LABORATORY EQUIPMENT AND SUPPLIES (6640)
Timeline
    Description

    The Department of Veterans Affairs intends to award a sole-source contract to Illumina, Inc. for the provision of molecular testing reagents required by the Minneapolis VA Health Care System. This procurement involves a Firm Fixed Price Purchase Order for a base year plus four option years, specifically for next-generation sequencing reagents that are compatible with the VA's existing Illumina sequencers. The sole-source justification is based on the fact that Illumina is the only authorized supplier for these specialized reagents, with no alternative products approved for use on the VA's equipment. Interested vendors who believe they can meet the requirements are encouraged to submit capability statements by January 10, 2025, to the Contracting Officer, Traci Johannes, at traci.johannes@va.gov.

    Point(s) of Contact
    Traci JohannesContracting Officer
    (320) 654-7635
    traci.johannes@va.gov
    Files
    Title
    Posted
    The Department of Veterans Affairs plans to award a sole-source contract to Illumina, Inc. for the supply of molecular testing reagents necessary for the Minneapolis VA Health Care System. The contract, intended as a Firm Fixed Price Purchase Order for a base year and four option years, arises from the unique requirement for specialized next generation sequencing reagents compatible with the VA’s existing Illumina sequencers. Although this notice is not a request for competitive proposals, interested vendors that can meet the specifications may submit capability statements. The justification for sole sourcing emphasizes that Illumina is the only company authorized to provide these specific reagents, with no other vendors' products approved for use on the sequencers owned by the VA. Market research confirmed that the anticipated pricing is fair and reasonable despite a projected 7% increase, which is higher than the expected 2-5%. The notice outlines necessary qualifications for potential vendors and explains the government's discretion in deciding to solicit offers based on responses received. Responses must be submitted by January 10, 2025, to the designated Contracting Officer via email.
    Lifecycle
    Title
    Type
    Similar Opportunities
    6550--Notice of Intent to Sole Source - Minneapolis VA Medical Center - FDA-Approved Microgenics DRI Ecstasy Plus Assay Reagent used with Beckman AU480 Analyzers
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs intends to negotiate a sole source contract with Microgenics Corporation for the procurement of FDA-approved Microgenics DRI Ecstasy Plus Assay Reagent, which is essential for use with Beckman AU480 Analyzers at the Minneapolis VA Medical Center. This contract action is being pursued under the authority of FAR 13.106-1, which allows for sole source awards when only one source is available to meet the government's requirements. The reagents are critical for in-vitro diagnostic testing, ensuring accurate and timely results for patient care. Interested vendors who believe they can meet the requirements are invited to submit a capability statement by 12:00 PM Central Time on January 9, 2025, to Alisha Milander at Alisha.Milander@va.gov, with all submissions needing to include registration details in the System for Award Management (SAM).
    65--Illumina Reagents and Consumables
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Heart, Lung, and Blood Institute (NHLBI), intends to award a non-competitive contract to Illumina, Inc. for the supply of "Illumina Reagents and Consumables" essential for various sequencing and genotyping systems. This procurement is driven by the unique operational needs of NIH-owned systems, as confirmed by market research indicating that only Illumina can provide the proprietary reagents necessary to maintain research integrity and support ongoing studies. The contract performance period is set from September 3, 2025, to September 2, 2030, and interested parties may submit capability statements for review by January 6, 2025; however, this is not a solicitation for proposals. For further inquiries, interested parties can contact Ethan J. Mueller at ethan.mueller@nih.gov or by phone at +1 301 496 2153.
    Lab Reagents for Pathology Dept. at WRNMMC
    Active
    Dept Of Defense
    The Defense Health Agency (DHA) intends to award a sole source contract to Roche Diagnostics Corporation for the procurement of specialized lab reagents and consumables necessary for molecular diagnostics testing in the Pathology Department at Walter Reed National Military Medical Center (WRNMMC). This procurement is critical for testing viral pathogens and is supported under the authority for non-competitive purchases, as Roche is the sole supplier of the proprietary materials required for use with the existing Roche medical equipment at WRNMMC. Interested parties may submit their qualifications by January 10, 2025, via email to the primary contact, Ealed Nuru, at ealed.m.nuru.civ@health.mil, with a copy to Erica S. Oh at erica.s.oh.civ@health.mil. The government retains discretion over the contract award process and is not obligated to seek competitive bids despite any expressions of interest received.
    6640--06 BACT/ALERT VIRTUO Blood Culture System, Consumables, and Support
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking to establish a sole-source Indefinite Delivery Indefinite Quantity (IDIQ) contract for the BACT/ALERT VIRTUO Blood Culture System, including necessary consumables and support services, to be utilized across multiple laboratories within VISN 6. This procurement aims to ensure the provision of a fully automated blood culture testing system, which is critical for healthcare services provided to veterans, with the contract expected to commence on November 29, 2024. The decision to pursue a sole-source contract with BioMerieux Incorporated follows market research indicating that these specialized items are exclusively available from the original equipment manufacturer, thereby avoiding delays and additional costs. Interested parties may express their capabilities to Contract Specialist Stephanie McElmore via email by November 19, 2024, and should clearly indicate their business status regarding size and ownership.
    6630--Notice of Intent - Sole Source Bridge Contract - Integrated Chemistry CPRR
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the Network Contracting Office 17, intends to award a sole source bridge contract to Beckman Coulter, Inc. for an integrated chemistry Cost-Per-Reportable Result (CPRR) program. This procurement includes equipment rental and maintenance services, as well as 103 different chemistry and immunochemistry tests, ensuring the provision of necessary reagents, controls, and consumables for the Central Texas Veterans Health Care System. The contract is crucial for maintaining laboratory operations during the transition to new equipment analyzers, with the anticipated period of performance from January 15, 2025, to October 14, 2025. Interested parties may submit capability statements for consideration within seven days of this notice, after which the contract will be finalized with Beckman Coulter, Inc. if no other responses are received. For further inquiries, contact Kathryn Prose at kathryn.prose@va.gov or (254) 217-2835.
    Special Notice- Intent to Sole Source Award the Purchase of Lab Instruments to Agilent Technologies Inc.
    Active
    Dept Of Defense
    The Department of Defense, specifically the U.S. Army Contracting Command – Aberdeen Proving Ground, intends to award a sole source contract to Agilent Technologies Inc. for the purchase of specialized lab instruments, namely the Seahorse XF and xCELLigence systems. These instruments are essential for conducting precise physiological measurements critical to military ration development and ongoing research efforts at the U.S. Army Combat Capabilities Development Command – Soldier Center. The procurement is justified based on the unique capabilities of Agilent's systems, which are not available from other vendors, and is necessary to avoid significant operational setbacks in military research missions. Interested parties may express their interest and capabilities by contacting Edmund J. Bousaleh and Alejandro Ayala via email by 1500 HRS ET on January 14, 2025, with the contract funded through Research, Development, Test, and Evaluation (RDT&E) for fiscal year 2024.
    Sources Sought Phadia Test Kits and Supplies
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the Network Contracting Office 5, is seeking sources for the procurement of Phadia test kits and supplies, including reagents for its ImmunoCap Allergy and ELiA Autoimmunity solutions. This Sources Sought Notice is intended for planning purposes only and will not result in a contract award; it aims to gather information on available suppliers and their capabilities. The anticipated procurement will be structured as a firm-fixed-price Indefinite Delivery Indefinite Quantity contract, potentially spanning five years, with deliveries to the VAMHCS Baltimore warehouse. Interested suppliers must respond by January 6, 2025, providing company details and socio-economic status to Alison Klein at ALISON.KLEIN@VA.GOV.
    J065--O-Arm Service Agreement Maintenance
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) intends to award a sole source contract for an O-Arm Service Agreement Maintenance to MEDTRONIC, Inc., which is recognized as the authorized distributor and service center for O-Arm equipment. This procurement aims to secure maintenance services essential for the operation and reliability of medical equipment used within the Veterans Health Administration. Interested vendors are invited to submit an authorized distribution letter and a capability statement to the contracting specialist, Matt Lee, at matthew.lee5@va.gov, within five days of this notice; otherwise, the contract will be awarded to MEDTRONIC without further notice. The procurement is governed by statutory authorities allowing for limited competition under the Federal Acquisition Regulation (FAR), ensuring compliance while streamlining the contracting process.
    7B22--Notice of Intent (NOI) to Sole Source Vitrea Server Services
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) intends to award a sole-source contract to Canon Medical Informatics, Inc. for Vitrea Server Services, which includes a 12-month base period and four additional 12-month option periods. This contract aims to provide comprehensive maintenance, support, and proprietary software updates for critical Vitrea equipment utilized by the Little Rock/Central Arkansas Veterans Healthcare System. Canon Medical has been identified as the only vendor capable of fulfilling these specific requirements based on market research, ensuring compliance with regulatory standards for quality healthcare delivery to veterans. Interested parties wishing to contest this sole-source intent must submit a letter of interest and appropriate authorization from Canon Medical by January 7, 2025, via email to Contract Specialist Carmyn E Williams at Carmyn.Williams@va.gov.
    J065 - Notice of Intent to Sole Source, Scriptpro Services and Support
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) intends to award a sole source contract for technical and maintenance support services to ScriptPro USA, Inc., specializing in surgical and medical instrument manufacturing. The procurement aims to secure comprehensive maintenance and support for ScriptPro medication dispensing systems at the Southern Nevada Health Care Services, ensuring that the systems are maintained according to OEM specifications and that certified technicians provide the necessary services. This contract is critical for the operational success of the VA's healthcare services, as it guarantees the efficient and safe functioning of essential medical dispensing technology for veterans. Interested parties can direct inquiries to Gary Christensen at gary.christensen@va.gov or by phone at 650-493-5000 x65825, with the contract period set from February 1, 2025, to January 31, 2026, and options for three additional years.